Z-2623-2026 Class II Ongoing

Recalled by Remel, Inc — Lenexa, KS

FDA device recall Z-2623-2026 was initiated by Remel, Inc on Jun 3, 2026 and is designated Class II. Reason for recall: Reduced or no recovery of some strains of Neisseria gonorrhoeae. The recall status is ongoing. Affected quantity: 1573.

Recall details

Product Type
Devices
Report Date
Jul 8, 2026
Initiation Date
Jun 3, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1573

Product description

GC Agar Base (150mm) 10/PK R04030; GC Agar Base (100mm) 10/PK R01460

Reason for recall

Reduced or no recovery of some strains of Neisseria gonorrhoeae.

Distribution pattern

Worldwide distribution - US Nationwide and the countries of Canada, Singapore, and the United Kingdom.

Code information

R01460 - GC Agar Base (100mm) 10/PK UDI-DI 848838001796 Lots 338950 356898 359912 365679 371863 376799 382136 384712 393488 396333 402458; R04030 - GC Agar Base (150mm) 10/PK UDI-DI 848838004469 Lots 336864 345992 348754 359925 367829 374235 376786 381488 385224 391312 393478

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2623-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2623-2026. Report a data issue: hello@regdatalab.com.